
The episode discusses the impact of including women in clinical trials since 1993 and its significance for human health and medical innovation.
What happened in 1993 still affects medicine today. That was the year women were required to be included in NIH-funded clinical trials, a shift that helped begin correcting decades of male-centered medical research. In this powerful conversation, Sharon Kedar CFA sits down with Jessica Federer, former Chief Digital Officer at Bayer and Managing Director of The Women’s Health Fund, to explore why this moment matters not only for women’s health, but for human health, innovation, and the future of medicine. They discuss how exclusion from research shaped diagnostics, drug dosing, autoimmune disease, heart health, cancer care, and why one of the world’s largest multi-trillion dollar industries still has enormous opportunity ahead. This Episode Is For You If: - You want to understand why women’s health impacts everyone - You’re curious how clinical trials shape modern medicine - You care about innovation, investing, longevity, and better healthcare outcomes What You’ll Learn: - Why women were historically excluded from many clinical trials - How 1993 changed medical research standards - Why better science creates better care for everyone Key Takeaways - Clinical research has…
Explore listener stats, chart rankings, contacts and more on the Innovate and Elevate podcast page.